New Online! New developments and applications of human organoids

Hi @bsky.app, I’m Humaira, a molecular biologist and protein scientist passionate about decoding complex biological systems and translating that knowledge into therapeutic insights.

We discovered a new AML vulnerability: TTLL4 glutamylates NPM1c and helps leukemia cells thrive. Knock it down and cells differentiate and survival improves. Collab between our lab and @Gritsman_lab—funded by NIH and DoD/CDMRP. Preprint: bit.ly/42oZl09 /1

TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia https://www.biorxiv.org/content/10.1101/2025.04.07.647605v1

TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated acute myeloid leukemia https://www.biorxiv.org/content/10.1101/2025.04.07.647605v1